Matt Saenz, | |
4301 W Markham St # 584, Little Rock, AR 72205-7101 | |
(501) 526-7485 | |
Not Available |
Full Name | Matt Saenz |
---|---|
Gender | Male |
Speciality | Student In An Organized Health Care Education/training Program |
Location | 4301 W Markham St # 584, Little Rock, Arkansas |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1053990481 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207P00000X | Emergency Medicine | V0145 (Texas) | Secondary |
390200000X | Student In An Organized Health Care Education/training Program | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Matt Saenz, 409 Londonderry Dr, Victoria, TX 77901-4572 Ph: () - | Matt Saenz, 4301 W Markham St # 584, Little Rock, AR 72205-7101 Ph: (501) 526-7485 |
News Archive
A collaborative agreement between CSIRO and two German organisations is providing Australian food companies with access to a new processing technology which uses low-energy electron beams rather than heat or chemicals to decontaminate food.
Researchers based in Belgium have developed a new antibody drug that is highly successful at neutralizing coronavirus disease 2019 (COVID-19) in Syrian hamsters. The new biologic was administered to the rodents and was found to be equally successful at neutralizing the original severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) strain, and also the new mutant variants, such as the South African and UK strains.
Researchers from The University of Texas Health Science Center at San Antonio (UT Health San Antonio) and colleagues worldwide describe a new science-based intervention for hiccups in a research letter published June 18 in the journal JAMA Network Open.
Responders who worked at the World Trade Center site after the attacks on September 11, 2001, have an increased overall cancer incidence compared to the general population, particularly in thyroid cancer, prostate cancer, and, for the first time ever reported, leukemia, according to a Mount Sinai study published in JNCI Cancer Spectrum in January.
› Verified 1 days ago